Top Line Use of GLP-1 drugs such as semaglutide for weight loss has doubled over the past decade, but uptake among people with type 2 diabetes...
A recent study published in the journal Communication Medicine, US researchers used large-scale language models (LLMs) to analyse over 391,000 unique discussions about glucagon-like peptide-1 (GLP-1)...
Millions of Americans who have used popular obesity drugs such as semaglutide (Wegovy) to lose weight and improve their health are facing a new dilemma. “What...
From newer therapies for Alzheimer’s disease to developing off-the-shelf gene therapies for cancer, 2024 holds out hope for exciting developments in medicine that can transform our...
The study found all the participants had a clinically significant decrease in symptoms while they were using semaglutide Monday, December 4, 2023 6:11PM New research shows...
A weight loss jab called Wegovy is being rolled out by the NHS for patients with the highest medical need. (Subscribe: ——- Watch more of our...
Recent Comments